Literature DB >> 23489085

Simple method for differentiating measles vaccine from wild-type strains using loop-mediated isothermal amplification.

Tetsuo Nakayama1, Akihito Sawada, Hideyuki Kubo, Atsushi Kaida, Toshimitsu Tanaka, Naoki Shigemoto, Katsuhiro Komase, Makoto Takeda.   

Abstract

Because of increasing measles vaccine coverage, the proportion of patients with modified measles has been increasing. Such patients have low-grade fever with very mild eruptions similar to vaccine-related adverse events. Differentiation between these two pathogenic conditions is required to improve the quality of laboratory-based measles surveillance. In this study, vaccine-specific and wild-type specific primer sets were designed for loop-mediated isothermal amplification in the N gene, and vaccine strains, C1, D3, D4, D5, D8, D9, G3 and H1 wild strains were examined. Three vaccine strains were efficiently amplified using a vaccine-specific primer set with an approximately 10-times higher sensitivity than wild-type primer. Modified measles was differentiated from vaccine-associated cases by this system, but limitations were encountered with the other genotypes.
© 2013 The Societies and Wiley Publishing Asia Pty Ltd.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23489085     DOI: 10.1111/1348-0421.12029

Source DB:  PubMed          Journal:  Microbiol Immunol        ISSN: 0385-5600            Impact factor:   1.955


  2 in total

1.  Measles Vaccine-Associated Rash Illness in China: an Emerging Issue in the Process of Measles Elimination.

Authors:  Aili Cui; Huiling Wang; Zhen Zhu; Naiying Mao; Jinhua Song; Yan Zhang; Wenbo Xu
Journal:  J Clin Microbiol       Date:  2020-10-21       Impact factor: 5.948

2.  Utility of a Stressed Single Nucleotide Polymorphism (SNP) Real-Time PCR Assay for Rapid Identification of Measles Vaccine Strains in Patient Samples.

Authors:  Thomas Tran; Renata Kostecki; Michael Catton; Julian Druce
Journal:  J Clin Microbiol       Date:  2018-07-26       Impact factor: 5.948

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.